Greggs Introduces Smaller Portions and Protein Snacks for GLP-1 Users
Greggs has introduced smaller portions and protein-rich snacks to meet demand from customers using GLP-1 weight-loss drugs amid shifting eating habits, with 500,000 egg pots sold since autumn.
- In July, Greggs said it would target customers on GLP-1 weight-loss drugs by introducing smaller portions and protein-rich snacks, and on Thursday reported a 7.4% sales increase over the three months to December 27.
- This year the rise of GLP-1s and a broader health trend prompt demand for protein and fibre, with several firms noting changing appetites due to appetite-suppressing weight-loss drugs.
- The chain has introduced half a million egg pots since autumn and this week launched overnight oats, while hot snacks sold 1.3 million items weekly in 2025 alongside high-protein products.
- Greggs said it was cautious but hopeful about its outlook for 2026 after reporting lacklustre profits, and the boss said there is "no doubt" smaller portions affect the business's bottom line.
- Other retailers are also shifting ranges to target weight-loss jab users, with M&S launching a nutrient-dense range in December and policy moves like the UK government junk-food ad ban before 9pm plus shrinkflation reshaping portions.
11 Articles
11 Articles
Greggs profits hammered by Britain's fat jab obsession as habits shift from pastries and cakes
Greggs has confirmed that the growing use of appetite-suppressing weight loss injections is having an impact on customer behaviour and the bakery chain’s financial performance.Roisin Currie, chief executive at Greggs, said there was “no doubt” that medications such as Ozempic and Wegovy are changing what shoppers want to buy.She said customers are increasingly opting for smaller portions rather than the larger products traditionally associated w…
Greggs boss issues 'no doubt' warning over weight loss jabs
Greggs CEO Roisin Currie has said there is "no doubt" appetite-suppressing medication is having an impact on the bakery chain's business, though she highlighted a "broader health trend" is also emerging.
Greggs boss issues warning over weight-loss jabs
Greggs said it was “cautious but hopeful” about its outlook for 2026
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium








